May, 2019 - MJZanon IP Attorney - Expert Patent & Trademark Lawyer in Brazil

What’s in a Name? Chanel’s Global Quest to Protect the Name of a Color

Christian Louboutin, Tiffany & Co., Hermès, T-Mobile, and UPS, among others, have proven that specific colors a[sg_popup id=”2993″ event=”inherit”][/sg_popup]re protectable

Kalytera announces submission of patent application to the U.S. Patent and Trademark Office – New Cannabidiol (CDB) composition

Wednesday, May 29, 2019 DrugName : cannabidiol Kalytera Therapeutics, Inc. announced that it has filed a provisional patent application with the

Tokyo District Court renders judgment on the patent infringement lawsuit concerning Rituxan intravenous infusion

Wednesday, May 29, 2019 DrugName : rituximab Chugai Pharmaceutical Co., Ltd. announced that the Tokyo District Court has rendered judgment dismissing

BlueWillow Biologics announces issuance of intranasal Anthrax Vaccine patent

Wednesday, May 29, 2019 DrugName : anthrax vaccine BlueWillow Biologics announced the issuance of U.S. patent number 10,138,279 covering an

European Medicines Agency (EMA) Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review

Tuesday, May 28, 2019 | DrugName : trastuzumab biosimilar Prestige BioPharma (herein, Prestige) announced that European Medicines Agency (EMA) has